BP’s Jazz Pharmaceuticals JAZZ Stock Holding History

BP’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,443	Closed	-$256K	–	268
2021 Q2	$256K	Sell	1,443 -787	-35%	-$136K	0.01%	566
2021 Q1	$367K	Sell	2,230 -839	-27%	-$138K	0.01%	533
2020 Q4	$507K	Sell	3,069 -2,231	-42%	-$332K	0.02%	492
2020 Q3	$756K	Sell	5,300 -400	-7%	-$49.6K	0.02%	463
2020 Q2	$629K	Hold	5,700	–	–	0.02%	485
2020 Q1	$568K	Hold	5,700	–	–	0.02%	454
2019 Q4	$851K	Buy	+5,700	New	+$776K	0.03%	453
2018 Q4	–	Sell	-7,000	Closed	-$1.18M	–	460
2018 Q3	$1.18M	Hold	7,000	–	–	0.04%	413
2018 Q2	$1.21M	Hold	7,000	–	–	0.04%	428
2018 Q1	$1.06M	Hold	7,000	–	–	0.04%	399
2017 Q4	$942K	Sell	7,000 -16,000	-70%	-$2.22M	0.03%	415
2017 Q3	$3.36M	Hold	23,000	–	–	0.12%	214
2017 Q2	$3.58M	Buy	+23,000	New	+$3.52M	0.13%	204

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

BP's JAZZ Position: Q3 2021 in Review

BP sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2021, closing a stake of 1,443 shares — an estimated $256K sold.

BP first reported a position in JAZZ in Q2 2017 and held it in 13 quarters. The position peaked at $3.58M in Q2 2017. 455 funds tracked by Wall St. Rank hold JAZZ as of Q3 2021.

BP reported no remaining Jazz Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
BP sold 1,443 Jazz Pharmaceuticals shares in Q3 2021, an estimated $256K.
BP first reported a position in Jazz Pharmaceuticals in Q2 2017 and held it in 13 quarters.
BP's Jazz Pharmaceuticals position peaked at $3.58M in Q2 2017.
455 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2021.

Based on BP's 13F filing for Q3 2021, filed 10 Nov 2021.